Acadian Asset Management
IMA

Acadian Asset Management’s ImageneBio Inc IMA Stock Holding History

Acadian Asset Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,464
Closed -$278K – 1908
2025
Q2 		$278K Hold
17,464
– – ﹤0.01% 1251
2025
Q1 		$266K Sell
17,464
-6,567
-27% -$113K ﹤0.01% 1199
2024
Q4 		$471K Sell
24,031
-3,112
-11% -$62.9K ﹤0.01% 1089
2024
Q3 		$562K Hold
27,143
– – ﹤0.01% 1055
2024
Q2 		$536K Buy
27,143
+3,578
+15% +$63.2K ﹤0.01% 1171
2024
Q1 		$400K Buy
23,565
+21,755
+1,202% +$396K ﹤0.01% 1063
2023
Q4 		$41K Buy
1,810
+960
+113% +$31.3K ﹤0.01% 1482
2023
Q3 		$44K Sell
850
-99
-10% -$5.96K ﹤0.01% 1445
2023
Q2 		$72K Sell
949
-159
-14% -$11.4K ﹤0.01% 1470
2023
Q1 		$45K Hold
1,108
– – ﹤0.01% 1528
2022
Q4 		$34K Hold
1,108
– – ﹤0.01% 1635
2022
Q3 		$45K Buy
1,108
+258
+30% +$14.9K ﹤0.01% 1511
2022
Q2 		$45K Buy
+850
New +$46.9K ﹤0.01% 1510

Other funds holding IMA

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management's IMA Position: Q3 2025 in Review

Acadian Asset Management sold out of ImageneBio Inc (IMA) in Q3 2025, closing a stake of 17,464 shares — an estimated $278K sold.

Acadian Asset Management first reported a position in IMA in Q2 2022 and held it in 13 quarters. The position peaked at $562K in Q3 2024. 33 funds tracked by Wall St. Rank hold IMA as of Q3 2025.

  • Acadian Asset Management reported no remaining ImageneBio Inc position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 17,464 ImageneBio Inc shares in Q3 2025, an estimated $278K.
  • Acadian Asset Management first reported a position in ImageneBio Inc in Q2 2022 and held it in 13 quarters.
  • Acadian Asset Management's ImageneBio Inc position peaked at $562K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.